Abstract
The synthetic eicosapeptide amide of Hofmann, comprising the N-terminal sequence 1 to 20 of corticotropin A1S, in which the twentieth amino acid valine is in the form of the amide, has been investigated for adrenal and extra-adrenal effects by in vivo and in vitro techniques. The adrenal activities assayed were in vivo steroidogenesis in 24-hr hypophysectomized rats and in vitro steroidogenesis by quartered rat adrenals. The in vitro release of free fatty acids by rat epididymal adipose tissue and the mobilization of free fatty acids and the depression of blood sugar in the intact mouse were the extraadrenal effects measured. All activities were assayed relative to corticotropin A1 on a weight basis. The activities of the eicosapeptide amide in the in vitro assays were steroidogenesis, 181%, adipokinetic effect, 160%, and hypoglycemia, 200%. By in vitro techniques the steroidogenic effect was 78% and the adipokinetic effect was 39%. Thus, by in vivo assays the eicosapeptide amide has the same molar activity as corticotropin in both adrenal and extra-adrenal effects. This is the minimum chain length which has been shown to have full corticotropin activity. The comparison of in vivo and in vitro assays showed that in vitro techniques may give erroneous estimates of the true biological activity of a synthetic peptide, presumably because of instability of the peptides in in vitro systems. (Endocrinology75: 831,1964)